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Abstract.  Recent studies using the fungal metabolite 
brefeldin A  (BFA) have provided important  insights 
into the dynamics and the organization of the ER/Golgi 
membrane  system. Here we examined the effect of 
BFA on the functional integrity of the distal part of 
the secretory pathway,  i.e.,  transport between trans- 
Golgi cisternae and the cell surface. To assay export 
via the constitutive pathway,  we followed the move- 
ment of vesicular stomatitis virus (VSV) G  glycopro- 
tein that had been accumulated in the trans-Golgi net- 
work (TGN) by incubation of infected BHK-21 cells at 
20~  Addition of BFA rapidly and reversibly inhib- 
ited cell surface transport of G protein.  The block to 
secretion was not due to redistribution of externalized 
G protein to internal  pools. It was also not due to col- 
lapse of TGN to the ER,  since VSV G protein blocked 
in treated cells resided in compartments that were dis- 
tinct from the ER/Golgi system.  Similar effects were 
found with a bulk-flow marker:  BFA blocked constitu- 
tive secretion of glycosaminoglycan chains that had 
been synthesized and sulfated in the trans-Golgi cister- 
nae.  To examine export via the regulated secretory 
pathway,  we assayed secretion of [35S]SO4 labeled se- 
cretogranin II from PC12 cells,  a marker that has been 
used to study secretory granule  budding from the 
TGN (Tooze,  S. A.,  U. Weiss, and W.  B. Huttner. 
1990.  Nature [Lond.].  347:207-208).  BFA potently in- 
hibited secretion of sulfated secretogranin II induced 
by K + depolarization.  Inhibition was at the level of 
granule formation,  since BFA had no effect on regu- 
lated secretion from preformed granules.  Taken  to- 
gether,  the results  suggest that BFA blocks export via 
both the constitutive and the regulated pathways. In 
contrast,  endocytosis and recycling of VSV G protein 
were not blocked by BFA, consistent with previous 
studies that endocytosis is unaffected (Misumi,  Y.,  Y. 
Misumi, K.  Miki, A  Takatsuki,  G.  Tamura,  and Y. 
Ikehara.  1986. J.  Biol.  Chem.  261:11398-11403). 
These and earlier results suggest that the exo/endocytic 
pathway of mammalian cells consist of two similar but 
distinct endomembrane systems: an ER/Golgi system 
and a post-Golgi system. BFA prevents forward trans- 
port without affecting return traffic in both systems. 
p 
ROTEIN secretion from eukaryotic cells follows a path- 
way by which secretory products are transferred  se- 
quentially  through  a series of intracellular  compart- 
ments.  Transport  is generally believed to be mediated by 
vesicular carriers (Palade,  1975; Farquhar and Palade,  1981; 
Pfeffer and Rothman,  1987), the best documented case being 
secretory granules involved in the final stage of regulated se- 
cretion.  Evidence is accumulating  for the involvement of ve- 
sicular carriers in other transport steps. Inhibition  of trans- 
port by certain mutations or inhibitors  (Schekman,  1982; 
Orci et al., 1989; Kaiser and Schekman,  1990) results in ac- 
cumulation of vesicles that have been suggested to function 
as  transport  intermediates.  In  addition,  cell-free systems 
have been used to study the formation of these vesicles in vi- 
tro  (Malhotra  et al.,  1989;  Wandinger-Ness  et al.,  1990; 
Groesch et al., 1990; Tooze and Hutmer, 1990; Tooze et al., 
1990; Rexach and Schekman,  1991; d'Enfert et al.,  1991). 
Several of the putative transport vesicles have recently been 
isolated and characterized  (Lodish et al.,  1987; Walworth 
and Novick, 1987; Holcomb et al., 1988; Paulik et al., 1988; 
Groesch et al.,  1990; Wandinger-Ness  et al.,  1990; Tooze 
and Huttner,  1990; Rexach and Schekman,  1991). In some 
cases, these vesicles have been shown to represent bona fide 
transport intermediates  since they are able to complete trans- 
port when incubated in a second reaction with the appropri- 
ate acceptor membrane (Groesch et al.,  1990; Rexach and 
Schekman,  1991). 
A central question is how the vesicles are generated  from 
individual donor compartments,  and whether a common set 
of proteins  is involved in each intercompartmental  transfer 
step. Insight into this problem has been provided by studies 
using  a  fungal  metabolite,  brefeldin  A  (BFA). ~ BFA pre- 
vents the exit  of newly  synthesized  proteins from the ER 
1. Abbreviations  used in thispaper: BFA, brefeldin A; BiP, binding protein; 
GAG, glycosaminoglycan;  Rh-transferrin,  rhodamine-conjugated  human 
transferrin; TGN, trans-Golgi  network; VSV G, G glycoprotein of vesicular 
stomatitis virus. 
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to  rapid  disruption  of Golgi  structure  and  microtubule- 
dependent retrograde transport of cis-, medial-, and trans- 
Golgi enzymes back to the ER (Lippincott-Schwartz et al., 
1989; Doms et al., 1989; Bosshart et al., 1991; Russ et al., 
1991). These results suggest that BFA blocks forward trans- 
port  between the  ER  and Golgi complex while allowing 
retrograde transport to continue. An exciting finding is that 
BFA causes rapid (<15  s) dissociation of a  l l0-kD protein 
from Golgi membranes (Donaldson et al., 1990).  This pro- 
tein,  &COP,  has  been  shown to  be  a  component of the 
nonclathrin-coated  vesicles  that  accumulate  when  inter- 
cisternal Golgi transport is blocked by GTP3,S (Malhotra, 
1989; Serafini et al., 1991). BFA prevents formation of this 
type of vesicle in vitro (Orci et al., 1991), supporting the no- 
tion that/3-COP participates in coat assembly. Interestingly, 
/3-COP  shares  some  sequence  identity  with  /%adaptin 
(Duden et al., 1991a,b),  a protein involved in the assembly 
of clathrin coats (for reviews see Pearse and Crowther, 1987; 
Ponnambalam et al., 1990).  Like the clathrin coats,/3-COP 
was found to be present in a multisubunit protein complex, 
termed "coatomer" (Waters et al., 1991). These findings are 
consistent  with  a  model  that  /3-COP, and  therefore  the 
coatomer complex,  plays an essential role in the  forward 
transport between the ER and Golgi complex, and between 
early Golgi compartments. 
Whether H-COP and the coatomer complex also function 
in distal parts of the Golgi complex is not clear. Data thus 
far suggests that BFA does not affect the trans-Golgi network 
(TGN).  For  example,  in  contrast  to  the  proximal  Golgi 
cisternae, the TGN does not appear to collapse into the ER, 
since newly synthesized proteins blocked in the ER are not 
modified  by  the  TGN-resident  enzyme,  sialyltransferase 
(Doms  et  al.,  1989).  Furthermore,  mannose-6-phosphate 
receptors labeled at the cell surface can still return to the site 
of sialylation in the presence of BFA, indicating that endo- 
cytic traffic from the cell surface to the TGN is unaffected 
(Chege and Pfeffer,  1990).  On the other hand, double im- 
munofluorescence localization using antibodies specific for 
H-COP and the G glycoprotein of vesicular stomatitis virus 
(VSV G) demonstrated that these two proteins are colocal- 
ized when biosynthetic transport is blocked at either  15~ 
(a pre-Golgi compartment) or 20~  (TGN)  (Duden et al., 
1991b; Miller, S. G., and H.-P. Moore, unpublished obser- 
vations). In this paper, we address the question of whether 
exit from the TGN can still occur in BFA-treated  cells. We 
find that transport from trans-Golgi compartment to the cell 
surface, via both the constitutive and regulated pathways, is 
rapidly inhibited upon treatment with BFA. In contrast, en- 
docytosis from the cell surface continues. Thus, BFA exerts 
similar effects on pre- and post-Golgi traffic, blocking for- 
ward transport but not return traffic. 
Materials and Methods 
Materials 
BFA was obtained from Epicentre Technologies (Madison, WI) and stored 
as a  lO-mg/ml stock solution in  methanol at  -20~  Human transferrin, 
coupled to tetramethylrhodamine, was purchased from Molecular Probes, 
Inc.  (Eugene, OR). BHK-21  cells were obtained from the American Type 
Culture Collection (Bethesda, MD).  PCI2 cells were obtained from Dr. 
Stuart C. Feinstein (University of California, Santa Barbara, CA). Mouse 
mAb 865, specific for the extracellular domain of VSV G, was provided by 
Dr. L. Lefrancois (Scripps Clinic and Research Foundation, La Jolla, CA; 
Lefrancois and Lyles,  1982).  A rat mAb specific for the Ig heavy chain 
binding protein (BiP) was the kind gift of Dr. D. Bole (University of Michi- 
gan, Ann Arbor, MI. Rabbit anti-/3-COP was generated against a peptide 
corresponding to the VSALGIDFKVKTIYR sequence of/3-COP (Duden et 
al.,  1991a,b).  The peptide was conjugated to keyhole limpet hemocyanin 
via an NH2-terminal cysteine residue, and the antibodies were purified on a 
peptide affinity column. Fluorescein-conjugated secondary antibodies were 
purchased from Kirkegaard and Perry Labs., Inc.  (Gaithersburg, MD). 
Cell Culture 
BHK-21  cells were maintained at 37~  in a 5% CO2 atmosphere in MEM 
supplemented with Earle's balanced salt solution containing 10% tryptose 
phosphate broth and 10% FCS. PC12 cells were maintained in DME con- 
taining 5% enriched calf serum and 5% horse serum under 10%  CO2 at- 
mosphere. The cells were plated onto poly D-lysine-coated (50 p,g/ml) 12- 
well plates at a density of 5  ￿  103 per well and grown for 3-4 d before 
experiments. 
Metabolic Labeling and Cell Surface 
Immunoprecipitation of VSV G 
BHK-21  cells were plated at a density of 2  x  106 cells per 10-cm dish and 
grown until near confluency ("~48 h). The ceils were washed three times 
in serum-free growth medium buffered with 25 mM Hepes, pH 7.4, and in- 
cubated for 45 rain at 32~  in 2 ml of the same medium containing 10-15 
PFU/cell of a temperature-sensitive mutant of VSV, ts045. The medium was 
then removed, and 10 ml of growth medium containing 10% FCS and 25 
mM Hepes, pH 7.4, prewarmed to 39.5~  was added. The ceils were then 
incubated for 3,5 h at 39.5~  to allow the accumulation of VSV G in the 
ER.  The  cells  were  washed twice  with  5  ml  of Ca2+/Mg2+-free  PBS 
(prewarmed  to  40"C)  and  incubated  for  5  min  at  40~  in  1  ml  of 
Ca2+/Mg2+-free PBS supplemented with 5 mM EDTA to detach the cells. 
Suspended cells were transferred to a 1.5-ml polypropylene centrifuge tube, 
pelleted by spinning briefly in a microcentrifuge, and resuspended in 1 ml 
of labeling medium (methionine-free DME containing 26 mM Hepes, pH 
7.4) at 40~  The cells were washed twice with  1 ml of labeling medium 
by brief centrifugation and gentle resuspension, and then incubated for 10 
min at 400C  in 0.5  ml of labeling medium. To  label,  100 #1 of labeling 
medium  containing  500  #Ci  of  [sSS]methionine (1,100  Ci/mmol)  was 
added and the incubation continued for  10  min at 40~  Labeling was 
stopped by adding unlabeled methionine to a final concentration of 5 mM 
from a 0.2-M stock. The cells were further incubated for 5 min at 40~ 
and  then pelleted,  washed three times with 0.5  ml  of ice-cold growth 
medium containing 25 mM Hepes, pH 7.4,  and resuspended in 0.5 ml of 
the same medium. Two 40-#1 aliquots were removed for normalization, and 
the remaining cells shifted to a 19.5~  water bath for 2 h to accumulate VSV 
G in the TGN. Two 150-#1 aliquots of cell suspension were pelleted, and 
gently resuspended in 150 #1 of ice-cold Hepes-buffered medium containing 
either 0 or 5 #g/ml BFA.  The cells were shifted to 32~  for 60 min, and 
then shifted to an ice-water bath, and two 40-#1 aliquots were removed from 
each tube. Immunoprecipitation of total VSV G or VSV G present at the 
cell surface was then carried out as described previously (Miller and Moore, 
1991).  lmmunoprecipitated VSV G  was separated on a  10%  SDS-poly- 
acrylamide gel, dried, and exposed to a phosphorimager screen (Molecular 
Dynamics, Sunnyvale, CA); and the amount ofVSV G present in each frac- 
tion was quantitated using the ImageQuant program (Molecular Dynamics). 
Subcellular Fractionation  of VSV G 
BHK-21 cells, grown on four 10-cm plates, were infected with VSV ts045 
and incubated at 39.5~  as described above for cell surface immunoprecipi- 
tation. One plate was washed and then shifted to an ice/water bath for con- 
trol, and the remaining three plates were incubated for 2 h at 19.5"C  in 10 
ml of buffered growth medium containing  100 #g/ml cycloheximide. All 
subsequent incubations were in the presence of cycloheximide. One plate 
was kept in an ice/water bath, and the other two plates were incubated at 
320C in fresh buffered growth medium containing either 0 or 5 #g/ml BFA 
for 60 min. The plates were shifted to an ice/water bath, and all four plates 
were washed three times with  ice-cold homogenization buffer (10  mM 
Hepes, pH 7.4,250 mM sucrose), and lifted from the plates by gentle scrap- 
ing with a cell scraper in 5 ml of ice-cold homogenization buffer. The cells 
were pelleted by centrifugation and resuspended in 0.5 ml of homogeniza- 
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gauge needle and unbroken cells and nuclei were removed by centrifugation 
for 10 min at 1,000 g. 400 #1 of each postnuclear supernatant was loaded 
onto a step gradient containing 1 ml each of 50, 30, 27.5, 25, 22.5, 20,  17.5, 
15, 12.5, and 10% sucrose, all in D20 buffered with 10 mM Hepes, pH 7.4 
(Lodish et al., 1987).  The gradients were centrifuged for 3 h at 36,000 rpm 
at 4~  and 1-ml fractions were collected from the bottom. The protein from 
300-#1  aliquots of each gradient fraction was precipitated with TCA and 
separated on a 10% SDS-polyacrylamide gel. The gels were transferred to 
nitrocellulose, and probed with mAbs to either BiP (Bole et al.,  1986),  to 
confirm the localization of the ER, or a mAb specific for the cytoplasmic 
tail of VSV G (Kreis, 1986)  to localize total VSV G.  In separate experi- 
ments, VSV G was metabolically labeled as described above, and the local- 
ization of 35S-VSV G was determined on the gradients under each condi- 
tion. Similar results were observed in these experiments. 
lmmunofluorescence and 
Rhodamine-Transferrin Labeling 
BHK-21  cells were plated at 5  ￿  105 cells/well on glass coverslips and 
grown for 12-16 h before use. Infection with VSV ts045, accumulation of 
VSV G in either the ER at 40~  or TGN at  19.50C, and transport to the 
cell surface at 32~  were performed as described above.  For double label- 
ing  with  rhodamine-conjugated human transferrin,  (Rh-transferrin),  the 
cells were incubated with Rh-transferrin during the accumulation of VSV 
G in the TGN at 19.5~  as follows. After 30 rain at 19.50C, the media was 
aspirated from each coverslip and replaced with 2 ml of serum-free buffered 
growth medium preequilibrated at 19.5~  After a further 30 min at 19.5~ 
the medium was replaced with 2 ml of serum-free buffered growth medium 
containing 10/~g/ml of Rh-transferrin and the incubation continued for 1 h 
at  19.5~  At the end of the incubations the cells were cooled by shifting 
to an ice/water bath, washed twice with 10 ml of ice-cold PBS, twice with 
10 ml of ice-cold 10 mM acetic acid (pH 4.5)  to remove Rh-transferrin 
bound to the cell surface, and then three times with ice-cold PBS. The cells 
were fixed for 15 min at room temperature with 2 ml of 3 % paraformalde- 
hyde, 0.02 % glutaraldehyde in PBS. Cells were permeabilized after fixation 
by immersing for 10 s in -20~  methanol. After fixation and permeabiliza- 
tion the coverslips were washed three times in PBS, incubated for 10 rain in 
0.1%  NaBH4  in PBS at room temperature, and then washed three times 
in PBS. The coverslips were then incubated for 30 rain at room temperature 
in a 1:100 dilution of a mouse mAb that recognizes the lumenal domain of 
VSV G (Lefrancois and Lyles, 1982).  After washing three times in PBS, 
the cells were incubated for 30 rain at room temperature in a  1:25 dilution 
of fluorescein-conjugated goat anti-mouse antibody, washed with PBS, and 
mounted. Primary and secondary antibodies were diluted in PBS containing 
0.2%  gelatin. 
Internalization of VSV G  from the Cell Surface 
BHK-21  cells were plated at 5  x  105 cells/well on glass coverslips and 
grown  12-16 h  before use.  The cells were infected for 45  min with  10 
PFU/cell of VSV ts045 as described above, and then incubated for 2.5 h 
at 39.5~  to accumulate VSV G in the ER. All subsequent incubations con- 
tained 100 #g/ml cycloheximide. The cells were then incubated at 19.5~ 
for 2 h to mimic conditions used in BFA experiments, or directly shifted 
to 32~  for 1 h to accumulate VSV G on the cell surface. The cells were 
then incubated in fresh medium containing either 0 or 5/~g/ml BFA for 1 h 
at 32~  and then fixed, permeabilized, and processed for indirect immu- 
nofluorescence of VSV G as described above. 
Antibody Cross-linking and Internalization of VSV G 
at the Cell Surface 
BHK-21 cells plated on glass coverslips were infected with VSV ts045, and 
VSV G protein was accumulated on the cell surface as described above. The 
cells were then shifted to an ice/water bath and each coverslip was incubated 
in 100/~1 of buffered growth medium containing a 1:100 dilution of a mouse 
monoclonal ascites fluid specific for the extracellular domain of VSV G 
(Lefrancois and Lyles, 1982).  Excess antibody was then removed by wash- 
ing three times in ice-cold buffered growth medium. Cells were then in- 
cubated for an additional hour at 32~  in buffered growth medium contain- 
ing either 0 or 5 ~g/rnl BFA.  One set of cells was kept at 4~  during this 
1-h incubation as control, and a second set of cells was incubated for 1 h 
at 32~  in buffered growth medium containing 20 mM 2-deoxyglucose and 
10 mM sodium azide to deplete intracellular ATE The cells were then fixed 
as described above, and permeabilized for 10 s in  -20~  methanol. The 
cells were then incubated for 30 rain at room temperature with a 1:25 dilu- 
tion of fluorescein-conjugated  goat anti-mouse antibody, washed with PBS, 
and observed using a fluorescence microscope. 
Metabolic Labeling  and Analysis of  Regulated 
Secretion of Secretogranin II 
PC12  cells grown in 12-well  plates were starved for sulfate by incubating 
for 30 rain in a sulfate-free buffer (buffer A: 110 raM NaCl, 5.4 mM KC1, 
0.9 mM Na2HPO4,  20 mM Hepes, pH 7.2,  10 mM MgCl2, 2 mM CaCl2, 
and 1 g/liter glucose). The cells were then pulse-labeled in 250 #l of buffer 
A containing 1 mCi/ml [35S]SO4 for 5 min at 37~  to label secretogranins 
and sulfated proteoglycans. Cells were chased for the indicated time in a 
low potassium transport buffer (buffer B: 127 mM NaC1, 5 mM KC1, 0.33 
mM Na2HPO4, 0.44 mM KH2PO4, 4.2 mM Na HCO3, 20 mM Hepes, pH 
7.2,  2.2 mM CaCl2,  5,6 mM glucose) to allow the accumulation of regu- 
lated vesicles (Rosa et al., 1985).  In some experiments, BFA was added to 
the chase medium at a concentration of 5 pg/ml. To induce release from 
regulated granules, cells were depolarized with a  high potassium buffer 
(buffer C) with composition identical to buffer B, except that the concentra- 
tion of KCI was raised to 55 mM and the concentration of NaC1 decreased 
to 77 mM. Media samples were collected, precipitated with 10% TCA, and 
then centrifuged for 30 min at 3,000 rpm in a GPR centrifuge (Beckman 
Instrs., Inc., Fullerton, CA). The pellet was rinsed with 1 ml of -20~  ace- 
tone, and centrifuged for 5 min; the supernatant was aspirated and allowed 
to dry.  The pellet was then boiled for 5  rain in Laemmli sample buffer 
(Laemmli, 1970).  Cells were extracted by addition of 100 ~l of NDET (1% 
NP-40,  0.4% [wt/vol] deoxycholate, 66 mM EDTA, and 10 mM Tris,  pH 
7.4) to each well. The extracted cells were transferred to a microcentrifugc 
tube and centrifuged for 5 min in a microcentrifuge to pellet insoluble de- 
bris. One tenth of the extract was added to an equal volume of2x Laemmli 
sample buffer and boiled for 5 rain. The media and extract samples were 
separated on  12.5%  SDS-polyacrylamide gels, dried, and exposed to a 
phosphorimager screen. 
p~S]Sulfate Labeling and Analysis of Constitutive 
Secretion of Glycosaminoglycan Chains 
BHK cells grown on t2-well plates (5  ￿  105 cells/well) were incubated in 
buffer A containing 500/~M 4-methylumbelliferyl-/~-D xyloside for 30 rain 
at 37~  The cells were pulse-labeled for 2 rain at 37~  with buffer A con- 
taining 200 #Ci/ml  [35S]SO4 in the presence of xyloside, and chased in 
buffer A containing 5 mM Na2SO4 and 5 #g/ml BFA. At times indicated, 
the media samples were collected, and the cells were either extracted with 
Laemmli sample buffer for analysis by PAGE (Brion et al.,  1992),  or ex- 
tracted with Triton X-100 for filtration assay using cetylpyridinium chloride 
(Miller and Moore, 1991). For analysis by PAGE, 10/~g chondroitin sulfate 
was added to each media sample as carrier, and the samples were precipi- 
tated with acetone before loading onto gels as described (Brion et al., 
1992). 
Results 
Constitutive Transport of VSV G Protein 
from the 20~  Compartment to the Cell Surface 
Is Blocked by BFA 
Since BFA blocks transport from the ER to Golgi complex, 
to test its effects on transport from the TGN to the cell sur- 
face we needed to examine cargo molecules that already re- 
side within the TGN before BFA treatment. We therefore ex- 
amined the fate of VSV G protein that had been accumulated 
in the TGN by incubating VSV-infected cells at 20~  We 
used BHK-21 cells for these studies, because Griffiths et al. 
(1985)  have  performed  detailed  immunoelectron  micro- 
scopic studies showing that in these cells VSV G  accumu- 
lates in the TGN when incubated at 20~  BHK-21 cells were 
infected with the temperature-sensitive ts045 mutant of VSV 
and incubated at 40~  for 3.5 h to accumulate VSV G in the 
ER (Bergmann,  1989). Subsequent chases were carried out 
Miller et al. Post-Golgi Membrane Tra~c and Brefeldin A  269 Figure L  Immunofluorescence localization of VSV G proteins and B-COP in BHK-21 cells that had been infected with VSV ts045  and 
blocked at 20~  BHK-21 cells were infected with VSV ts045 for 45 min at 32~  and incubated for 3.5 h at 39.5~  to accumulate VSV 
G in the ER, and again for 2 h in the presence of cycloheximide at 19.5~  to accumulate VSV G in the TGN. The localization of VSV 
G proteins was compared with the Golgi marker,/~-COP,  by double indirect immunofluorescence. The cells were fixed, permeabilized 
with methanol, and reacted with affinity-purified rabbit antibodies against B-COP, and a mAb against the cytoplasmic tail ofVSV G protein. 
The locations of these proteins were then visualized using appropriate  fluorescent secondary antibodies.  (a-f) Two sets of cells double 
stained for VSV G protein (b and e) and B-COP (c and f). VSV G was visualized with fluoresceinated goat anti-mouse,  and ~-COP with 
rhodamine goat anti-rabbit antibodies. /3-COP was visualized with fluoresceinated goat anti-rabbit antibody. Bar, 20/~m. 
in media containing cycloheximide to prevent further synthe- 
sis of VSV G.  The ceils were first incubated  at 20~  for 
2  h  to allow the  accumulation of VSV G  at the TGN.  To 
confirm the intracellular location of the VSV G protein, we 
performed indirect immunofluorescence and compared the 
distribution of G protein with the Golgi marker, ~-COP. Fig. 
1  shows  that  in  cells infected with VSV and  incubated  at 
20~  VSV  G  protein is  colocatized with B-COP  (Fig.  1, 
a-f),  which  in  turn  is colocalized with clathrin  (data not 
shown).  In most cells, clathrin is concentrated in the TGN 
(Orci et al.,  1985;  Tooze and Tooze,  1986),  and y-adaptin, 
a  subunit of the clathrin adaptors of the Golgi complex, is 
colocalized with the TGN marker TGN-38 (Robinson, 1990). 
These results are consistent with the EM studies of Griffith 
et al. (1985) that the 20~  treatment results in accumulation 
ofVSV G proteins in the TGN. To test if transport to the cell 
surface can occur in the presence of BFA, cells that had been 
blocked at 20~  were shifted to 32~  in the presence or ab- 
sence of 5/~g/ml BFA for I h. VSV G protein that had reached 
the cell surface was detected by indirect immunofluorescence 
of fixed, unpermeabilized ceils. Fig. 2 shows that the amount 
ofVSV G protein transported to the cell surface after 15-120 
min at 32~  was greatly reduced in  the BFA-treated cells 
compared with untreated controls. To quantitate the extent 
of this inhibition, VSV G was pulse-labeled for 10 min with 
[35S]methionine  at the end of the 40~  block and then chased 
at 20~  for 2 h to accumulate the labeled population in the 
TGN. After shifting to 32~  for 1 h  in the presence or ab- 
sence of BFA, the amount of VSV G on the cell surface was 
determined by cell surface immunoprecipitation, SDS-PAGE 
separation of the immunoprecipitated protein, and quantita- 
tion using a phosphorimager. As shown in Fig. 3, the extent 
of transport of VSV G  was markedly inhibited by BFA. In 
the experiment shown, the fraction of VSV G transported to 
the cell surface during the 32~  chase decreased from 28.4% 
to 3.8%  in the presence of BFA, or by a factor of 7.5. Similar 
results were obtained when CHO cells were used in these ex- 
periments (not shown). 
The lack of VSV G protein on the cell surface could be ex- 
plained by two alternative mechanisms. The obvious expla- 
nation is that transport from the TGN to the cell surface is 
blocked by BFA. Alternatively, VSV G could be transported 
to the cell surface but, in the presence of BFA, become rap- 
idly internalized  after reaching the cell  surface,  such that 
very little VSV  G  is  present on the plasma membrane at 
steady state. The latter possibility was examined by looking 
at the effect of BFA on VSV G protein after it had reached 
the cell surface. BHK-21 ceils were infected with VSV ts045, 
incubated for 3 h at 39.5~  to accumulate VSV G in the ER, 
and then chased for 2 h at 32~  in the presence of cyclohex- 
imide to accumulate VSV G at the plasma membrane. The 
cells were then treated with 5/~g/ml BFA for an additional 
1 h at 32~  and the distribution of VSV G was assayed by 
indirect immunofluorescence on fixed cells. As shown in Fig. 
4 A, BFA does not cause redistribution of VSV G  from the 
cell surface; control and BFA-treated ceils showed similar 
The Journal of Cell Biology, Volume  118, 1992  270 Figure 2.  BFA inhibits  transport of VSV G from the 20~  compartment to the cell  surface.  BHK-21 cells  were infected  and incubated 
at 20~  to allow accumulation of VSV G proteins  in the TGN as in Fig.  1. Cells were then incubated  for 15 (a-d), 60 (e-h), or 120 min 
(i-l) either in the absence (a, b, e,f, i, and j) or presence (c, d, g, h, k, and l) of 5/~g/ml BFA plus cycloheximide.  The cells were then 
fixed and VSV G that had been transported to the cell surface was detected by indirect immunofluorescence  using an antilumenal  antibody 
without permeabilization.  (a,  d, e, h, i,  and l) Phase;  (b, c, f, g, j,  and k) fluorescence.  Bar, 60 #m. 
bright staining of  the cell surface (compare Fig. 4 A, b to Fig. 
2, c, g, and k). When cells were permeabilized before anti- 
body incubations, little or no internal staining was observed 
in either control or BFA-treated cells  (not shown).  To rule 
out this possibility that the G protein behaves differently in 
cells  that  had  been  incubated  at 20~  (since  experiments 
in Fig. 2  and Fig. 3 had this step),  we performed the same 
experiment  on  ceils  that  had  been  incubated  at  20~  for 
2  h.  Essentially  the  same results  were obtained:  cells  that 
had been treated with BFA (Fig. 4 B, e and  f) show the same 
bright cell surface staining as before the treatment (Fig. 4 B, 
a  and b) or mock-treated cells (Fig. 4 B, c and d).  Staining 
of permeabilized ceils also showed no detectable differences 
between control and BFA-treated cells  (not shown).  These 
observations  rule  out  the  possibility  that  BFA  shifts  the 
steady-state distribution of VSV G from the surface to intra- 
cellular  pools.  Taken  together,  these  results  indicate  that 
constitutive  transport  from the  TGN  to the cell  surface  is 
significantly inhibited  by BFA. 
VSV G Protein Blocked at 20~  Resides in 
a Compartment Distinct from the ER and Early 
Endosomes after BFA Treatment 
If transport between the TGN and the cell surface is blocked 
by BFA, what is the fate of VSV G that had been accumulated 
in the TGN? We examined the intracellular  localization of 
Figure 3.  Cell  surface immu- 
noprecipitation of VSV G af- 
ter treatment with BFA. BHK- 
21  cells  were  infected  with 
VSV ts045 for 45 min at 32~ 
incubated  for 3.5 h at 39.5~ 
to accumulate VSV G  in the 
ER, pulse-labeled  with  [35S]- 
methionine  for  10  min  at 
39.5~  (lane  1),  and  then 
chased for 2 h to accumulate 
3~S-labeled  VSV  G  in  the 
TGN (lane 2).  The cells were 
then incubated for 1 h at 32~ 
in the absence (lane 3) or pres- 
ence (lane 4) of 5/zg/ml BFA. 
VSV G present on the cell sur- 
face was immunoprecipitated 
(see  Materials  and Methods) 
and separated  by SDS-PAGE; 
and  35S-labeled VSV  G  was 
detected using a phosphorima- 
ger. (Lane 1) Immediately af- 
ter  pulse-labeling  at  39.5~ 
(lane 2) after 2 h accumulation 
at 19.5~  (lane 3) after 1 h of chase at 32~  -BFA; (lane 4) after 
32~  chase,  +BFA. In each case, the amount of total labeled  VSV 
G protein  was immunoprecipitated  from detergent-extracted  cells 
and used  for normalization. 
Miller et al. Post-Golgi Membrane Traffic and Brefeldin A  271 Figure 4. BFA does not lead to 
loss of VSV G  from the cell 
surface.  (A)  BHK-21  cells 
were infected with VSV ts045 
for 45 min at 32~  incubated 
for 2.5 h at 39.5 ~  to accumu- 
late  VSV  G  in  the  ER,  and 
then chased for 1 h at 32~  in 
the presence of cycloheximide 
to accumulate VSV G on the 
plasma membrane.  The cells 
were then incubated for 1 h in 
the absence (a) or presence (b) 
of 5  #g/ml  BFA plus  cyclo- 
heximide.  The  cells  were 
then fixed and VSV G on the 
cell  surface  was  detected  by 
indirect  immunofluorescence 
using an antilumenal  antibody 
without permeabilization.  (B) 
Same as in A, except that after 
39.50C  incubation,  the  cells 
were first  incubated  at 20~ 
for  2  h  in  the  presence  of 
cycloheximide  to mimic con- 
ditions  used in the other ex- 
periments.  (a and b) Surface 
VSV G proteins before the ad- 
dition of BFA. (c and d) After 
a 1-h incubation at 32~  in the 
absence of BFA, and (e and f) 
after a 1-h incubation at 32~ 
in the presence of BFA. Bars: 
(A)  10/~m;  (B) 20/zm. 
VSV G  protein that had been accumulated in the TGN but 
prevented from reaching the cell surface by BFA. Cells were 
infected with VSV ts045, chased in the presence of cyclohex- 
imide at 20~  for 2 h, and then shifted to 32~  in the pres- 
ence  or  absence  of BFA.  Indirect  immunofluorescence  of 
fixed,  permeabilized  cells  show  that  in  BFA-treated  cells, 
VSV G protein was found in vesicular structures with altered 
morphology from untreated  cells  (compare Fig.  5 A,  b-d 
with a),  often concentrated in perinuclear region.  Some of 
these  structures  may  colocalize  with  the  microtubule  or- 
ganizing center  (also  see Fig.  8),  similar  to the structures 
seen  by  Reaves  and  Banting  (1992)  using  a  TGN  marker, 
TGN-38, in BFA-treated normal rat kidney cells. Untreated, 
control cells rapidly lost internal  staining as most of the G 
protein was chased to the cell surface (not shown). Note that 
in BFA-treated ceils, little or no staining of the ER was ob- 
served. This pattern is in marked contrast to experiments in 
which BFA was added during the 20~  incubation;  in this 
case diffuse reticular  staining charecteristic of the ER was 
observed  throughout  the  cytoplasm,  in  addition  to  bright 
staining of the nuclear envelope (Fig. 5 B, b). Thus, VSV G 
resides  in  a  compartment distinct  from the  ER after  BFA 
treatment. This point was confirmed by subcellular fraction- 
ation.  VSV-infected BHK-21 cells were chased at 20~  for 
The Journal of Cell Biology,  Volume  118, 1992  272 2  h  in the presence of cycloheximide, and then shifted to 
32~  for 1 h  in the presence or absence of BFA. The cells 
were then homogenized,  and the postnuclear  supernatant 
was  separated  on  sucrose/D20  gradients  (Lodish  et  al., 
1987).  Fig.  6  shows  that  VSV  G  in  BFA-treated  cells 
sedimented at a density that was distinct from the ER mem- 
branes.  The ER membranes, as marked by either VSV G 
blocked at 40~  (Fig. 6 a) or antibodies to the lumenal ER 
protein BiP (Fig. 6, d and f) (Bole et al.,  1986), were pre- 
dominantly found in fractions 2, and 3, whereas VSV G pro- 
tein in treated cells sedimented in fractions 4-6 (Fig. 6 e). 
These results indicate that the block to export from the TGN 
to the cell surface is not simply caused by the collapse of the 
TGN back to the ER. Instead, the TGN represents a separate 
Miller et al. Post-Gotgi Membrane Traffic and Brefeldin A  273 Figure 5. VSV G accumulated in the 20~  compartment does not redistribute to the ER in the presence of BFA. (A) BHK-21  ceils were 
infected with VSV ts045 for 45 min at 32~  incubated for 3.5 h at 39.5~  to accumulate VSV G in the ER, and then for 2 h in the presence 
of c3~loheximide at 19.5~  to accumulate VSV G in the TGN. Cells were then incubated for 0 (a), 15 (b), 60 (c), or 120 min (d) at 32~ 
in the presence of 5 #g/ml BFA plus cycloheximide. The cells were then fixed and permeabilized, and internal VSV G was detected by 
indirect immunofluorescence. (B) BHK-21 cells were infected with VSV ts045 for 45 min at 32~  and then incubated for 3.5 h at 39.5~ 
to accumulate VSV G in the ER. Cells were then incubated for 2 h at 19.5~  in either the absence (a) or presence (b) of 5/~g/ml BFA 
plus cycloheximide. The cells were then fixed and permeabilized, and internal VSV G was detected by indirect immunofluorescence. Bars, 
20/~m. 
entity distinct from the ER/Golgi membrane system, as has 
been previously suggested (Chege and Pfeffer,  1990). 
Recently, BFA has been found to affect the endosomal sys- 
tem,  causing early endosomes to  redistribute to a  perinu- 
clear location near the microtubule organizing center (Lip- 
pincott-Schwartz et al., 1991).  Since the VSV G-containing 
structures in BFA-treated cells are also often localized in this 
region of  the cell (see Fig. 5 A), we examined the distribution 
of endosomal structures labeled with Rh-transferrin in BFA- 
treated cells and compared it with those containing VSV G. 
The Journal of Cell Biology, Volume  118, 1992  274 Figure  6.  Subcellular  frac- 
tionation  of VSV G  and BiP 
after  treatment  with  BFA. 
BHK-21  cells  were  infected 
with VSV ts045 for 45 min at 
32~  incubated  for 3.5  h  at 
39.5~  to accumulate VSV G 
in the  ER (a),  and  again  for 
2 h at  19.5~  in the presence 
of cycloheximide  to accumu- 
late  VSV G  in the TGN (b). 
The cells were then chased for 
1 h at 32~  in the absence (c 
and d) or presence (e and f) of 
5  ~g/ml  BFA  plus  cyclohex- 
imide.  For  each  condition, 
cells  were  homogenized and 
postnuclear supernatants  were 
fractionated  on  sucrose/D20 
gradients. The proteins in each 
fraction  were  separated  by 
SDS-PAGE, transferred  to ni- 
trocellulose,  and probed with 
antibodies  specific  for either 
VSV  G  (a-c and  e)  or  BiP 
(d and f).  (a)  VSV  G  after 
3.5 h at 39.5~  (b) VSV G af- 
ter 2 h at  19.5~  (c) VSV G 
after  1 h  at  32~  in the  ab- 
sence  of BFA;  (d)  BiP  after 
1 h at 32~  in the absence of 
BFA; (e) VSV G after  1 h at 
32~  in the presence of BFA; 
and (f) BiP after 1 h at 32~ 
in the presence  of BFA. 
We first examined the effect of BFA treatment on the intracel- 
lular distribution  of Rh-transferrin.  BHK-21  cells  were la- 
beled with Rh-transferrin for 1 h at 37~  and then incubated 
for varying times in the presence of 5/zg/ml BFA before fixa- 
tion and examination using a fluorescence microscope. Fig. 
7  shows that BFA causes a rapid redistribution  of Rh-trans- 
ferrin-labeled structures into tubular structures.  By 2 h the 
Rh-transferrin  was  found in a  dense  meshwork of tubular 
structures, often in the perinuclear region of  the cell. Double- 
labeling experiments in VSV-infected cells showed that these 
structures,  although localized to similar regions within the 
cell,  were distinct  from those containing VSV G  (Fig.  8). 
Thus, VSV G blocked within BFA-treated cells resides within 
a compartment that is largely distinct from early endosomes 
labeled by Rh-transferrin.  At this point, we cannot rule out 
the possibility that the structures containing VSV G protein 
are in communication with endosomes,  as has been shown 
for TGN-38 and mannose-6-phosphate receptor (Lippincott- 
Schwartz et al.,  1991; Wood et al.,  1991). The effects of BFA 
on these  post-Golgi endomembrane  systems is  completely 
reversible; upon removal of BFA, VSV G was rapidly trans- 
ported to the cell surface and the endosomal compartment 
labeled by Rh-transferrin returned to its normal morphology 
(data not shown). 
Endocytosis of VSV G and Rh-Transferrin Continues 
in the Presence of  BFA 
The above data suggest that export from the TGN to the cell 
surface via the constitutive pathway is blocked by BFA. VSV 
G is known to be internalized from the cell surface into early 
endosomes, where it either recycles to the cell surface or is 
directed to lysosomes (Gottlieb et al.,  1986; Gruenberg and 
Howell,  1987).  When VSV G  on the cell surface  is cross- 
linked by antibodies, recycling to the cell surface is abolished 
and internalized VSV G is targeted to the lysosomal pathway, 
resulting  in  a  rapid  loss  of VSV  G  from the  cell  surface 
(Gruenberg and Howell,  1987). To test whether endocytosis 
continues  in the  presence  of BFA,  BHK-21  cells  were  in- 
fected with VSV ts045; and VSV G  was accumulated in the 
ER by incubation at 39.5~  for 2.5 h and then chased in the 
presence of cycloheximide at 32~  for 1 h to allow transport 
to the cell surface. An antibody that recognizes the extracel- 
lular domain ofVSV G was added to the cells at 4~  for 1 h. 
Excess unbound antibody was removed and the cells  were 
warmed to 32~  for 1 h to allow endocytosis to occur. The 
cells were then fixed and permeabilized, and internalized an- 
tibody was visualized with a fluorescent secondary antibody 
(Fig. 9). In both control and BFA-treated cells, the antibodies 
were found in large,  extremely bright,  vesicular structures 
and a concomitant decrease in cell surface staining was ob- 
served.  No  difference  was  detected  between  control  and 
BFA-treated cells.  These structures were not detected when 
the permeabilization step was omitted (not shown), and their 
formation required energy,  since incubation at 32~  in the 
presence of 2-deoxyglucose and sodium azide prevented in- 
ternalization (Fig. 9, a and b). The internal VSV G-contain- 
ing structures bear a striking resemblance to those observed 
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 Figure  8.  Double  labeling 
of internalized  Rh-transferrin 
and  VSV  G  after  treatment 
with BFA. BHK-21 cells were 
infected  with  VSV ts045  for 
45 min at 32~  incubated for 
3.5 h at 39.5~  to accumulate 
VSV G in the ER, and then in- 
cubated for 2 h in the presence 
of cycloheximide at 19.5~  to 
accumulate  VSV  G  in  the 
TGN.  The  early  endosomal 
compartment  was  labeled 
with Rh-transferrin during the 
19.5~  incubation as described 
in  Materials  and  Methods. 
The cells were then chased at 
32~  for 15 (a and b), 60 (c 
and d), and 120 min (e-h) in 
the presence of 5/~g/ml BFA 
and  10  t~g/ml Rh-transferrin 
plus cycloheximide. The cells 
were fixed and permeabilized, 
and  internal  VSV  G  was 
detected by indirect immuno- 
fluorescence  using  a  fluores- 
cein-conjugated secondary an- 
tibody (b, d,f, and h). Internal 
Rh-transferrin  was visualized 
using rhodamine optics (a, c, 
e, and g). Bar, 20/~m. 
when cells expressing VSV G  were incubated with chloro- 
quine to prevent recycling of endocytosed VSV G to the cell 
surface (Gottlieb et al.,  1986).  We conclude that VSV G is 
still internalized in the presence of BFA. This result was fur- 
ther confirmed by using Rh-transferrin.  Incubation of cells 
pretreated in BFA with Rh-transferrin resulted in uptake of 
the marker into reticular structure similar to those shown in 
Fig. 7, indicating that endocytosis into early endosomes was 
not blocked (not shown).  These results are consistent with 
those obtained by Misumi et al. (1986), who showed that en- 
docytosis and degradation of asialofetuin was not affected. 
Two lines of evidence suggest that recycling from the early 
endosomal compartment to the cell surface is not blocked by 
BFA.  First,  such a block would lead to the loss of VSV G 
from the cell surface, as has been reported when this step is 
blocked by chloroquine (Gottlieb et al.,  1986);  this did not 
occur in the presence of BFA (see Fig. 4).  Second, endocy- 
tosed  Rh-transferrin  was rapidly  lost from the  cells upon 
removal of extracellular Rh-transferrin, even in the presence 
of BFA (not shown),  suggesting that recycling was not im- 
paired by BFA. Thus, trafficking between the cell surface and 
endosomes remains functional in the presence of BFA. 
Constitutive Secretion  of Sulfated Glycosaminoglycan 
Chains Is Blocked by BFA 
In  the  above  experiments,  we  examined  transport  of  a 
membrane-bound cargo protein. To test the effect of BFA on 
soluble  molecules,  we  determined  the  effects  of BFA  on 
secretion of sulfated glycosaminoglycan (GAG) chains.  We 
Miller et al.  Post-Golgi  Membrane  Traffic and Brefeldin  A  277 Figure 9. BFA does not block endocytosis of cell surface VSV G protein cross-linked with antibodies. BHK-21 cells were infected with 
VSV ts045 for 45 min at 32~  incubated for 2.5 h at 39.50C to accumulate VSV G in the ER, and then incubated for 1 h in the presence 
of cycloheximide at 32~  to accumulate VSV G on the plasma membrane. The cells were then incubated at 4~  for 1 h with an mAb 
that recognizes the extracellular domain of VSV G. The cells were washed to remove unbound antibody, warmed to 32~  for 1 h in the 
presence of cycloheximide, and fixed; and VSV G was localized using a fluorescein-conjugated secondary antibody after permeabilization. 
(a and b) Cells incubated at 32~  in the presence of 2-deoxyglucose and sodium azide; (c and d) control cells incubated at 32~  (e and 
f) cells incubated at 32~  in the presence of 5 #g/ml BFA. Bar, 20 #m. 
have shown previously that GAG chains serve as a convenient 
bulk-flow marker for the constitutive pathway (Miller and 
Moore,  1991).  GAG chains are sulfated in the trans Golgi 
thus sulfated GAG chains can be used to monitor transport 
between distal  Golgi compartments  and  the  cell  surface. 
When BFA was added to the cells before pulse-labeling with 
[3sS]SO~, no labeled GAG chains could be detected in the 
ceils. This is consistent with the recent findings that BFA un- 
couples initiation of GAG chain synthesis from elongation 
and sulfation, presumably because the former process oc- 
curs early in a Golgi compartment that collapses to the ER, 
whereas the latter processes occur later in Golgi cisternae 
that stay distinct from the ER (Spiro et al., 1991). To examine 
whether fully elongated, sulfated GAG chains synthesized in 
the absence of BFA can be secreted upon BFA treatment, we 
first incubated the cells with xyloside and pulse-labeled them 
with psS]SO, for 2 rain to allow synthesis of fully elongated, 
sulfated GAG chains. The cells were then chased in medium 
containing 5 ~g/ml BFA. As shown in Fig.  10 A, BFA po- 
tently blocked secretion of GAG chains. The sulfated chains 
remaining in the cells had the same mobility on SDS-PAGE 
as in control cells; no degradation was detected, as would be 
expected if they were diverted to other organelles such as 
lysosomes. The kinetics of GAG chain secretion was ana- 
lyzed by a precipitation filtration assay (Miller and Moore, 
1991),  The result  ffig.  I0  B) shows that  BFA inhibited  >96% 
The  Journal  of  Cell  Biology,  Volume 118,  1992  278 Figure I0. BFA blocks secretion of [35S]SO4 GAG chains via the constitutive pathway. (A) BHK-21 cells grown in 12-well plates were pre- 
incubated with 0.5 mM xyloside for 30 min at 37~  and pulse-labeled with [35S]SO4 for 2 min. The cells were then chased in medium 
containing 5/zg/ml BFA for 0, 15, or 30 min. Media and extract samples were analyzed by 18% PAGE  (see Materials and Methods). Media 
and extract samples from (lanes 1-6) control cells, or (lanes 7-12) BFA-treated  cells. (B) Secretion quantitated by cetylpyridinium chloride 
filtration assay. Cells were pulse-labeled as in A, and chased for 0,  10, 20, 30, 40, 50, and 60 min in medium containing 5/zg/ml BFA. 
Cells were extracted, and the amount of labeled GAG chains in media and extract samples were assayed by cetylpyridinium chloride precipi- 
tation and filtration. The fraction of total GAG chains secreted is plotted as a function of time. The total amount of labeled GAG chains 
recovered is 150,000 +  12,000 cpm (n  =  6) in control cells, and 140,000 5:4,000 cpm (n =  6) in BFA-treated cells. 
of GAG chains  secreted during a  1-h chase period.  GAG 
chains that were not secreted in BFA were quantitatively re- 
covered in the cell extracts. These results indicate that BFA 
inhibits export of both soluble and membrane-bound mole- 
cules from late Golgi compartments. 
Secretion of  Sulfated Secretogranin  H Is 
Blocked by BFA 
We next examined the effect of BFA on transport from the 
TGN to the cell surface via the regulated secretory pathway. 
We utilized PC12 cells for these studies since this cell line 
is known to secrete secretogranins by the regulated secretory 
pathway (Rosa et al.,  1985).  Moreover, secretogranins are 
modified by tyrosine sulfation, a process believed to occur 
in  the trans-most Golgi  cisternae (Baeuerle and  Huttner, 
1987;  Niehrs and Huttner,  1990). Thus, transport between 
this  compartment and  the  cell  surface can  be monitored 
using sulfated secretogranins. PC12 cells were pulse-labeled 
with pS]SO4 for 5 rain, and then chased in the presence of 
BFA  for  1  h  to  allow  the  accumulation  of  35S-labeled 
secretogranin in regulated secretory vesicles. The cells were 
then depolarized by incubation for 15 min in medium con- 
taining high K  + Ca  ~§  to  induce the regulated secretion of 
secretogranins. Fig.  11 A  shows that in control, untreated 
cells, K  § depolarization stimulated  secretion from a  basal 
level of  0.6% to 6.3% (Fig. 11 A, lanes 3 and 4). If, however, 
after pulse-labeling the cells were chased in the presence of 
BFA, secretion was almost completely blocked (Fig.  11 B, 
lanes 3 and 4): <0.6% of total labeled secretogranin II was 
secreted from either K§  or nonstimulated cells- 
or at least 10-fold lower than control cells. Notice that PC12 
secretes a sulfated proteoglycan via the constitutive pathway 
(Tooze and Huttner, 1990; see Fig.  11 A, lanes I  and 2, the 
smear migrating just below the start of the separation gel); 
in treated cells, secretion of this sulfated proteoglycan was 
also dramatically reduced (Fig.  11 B, lanes 1 and 2). Thus, 
BFA potently inhibited export from the TGN via both the 
constitutive and regulated secretory pathways.  The block is 
most likely due to inhibition of transport out of the TGN 
rather than a block to fusion of regulated secretory granules 
(Fig.  11  C  shows  that if the 35S-labeled secretogranin was 
first chased to mature granules before the addition of BFA, 
the drug no longer inhibited secretion from the  regulated 
pathway. 
Discussion 
Intracellular transport in eukaryotic cells is accomplished by 
sequential transfer between successive compartments. Each 
transport step involves very similar processes, i.e., genera- 
tion of vesicular intermediates, targeting of these vesicles to 
the  appropriate  compartment,  and  docking/fusion.  The 
similarities suggest that some components of the transport 
machinery may be used at multiple steps, while others must 
be unique to individual step to ensure the specificity of  trans- 
port. Earlier results suggested that the target for BFA might 
only function in early, but not in late, secretory compart- 
ments. In these earlier studies, however, the effect of export 
from distal Golgi compartments was not examined. In this 
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 paper,  we used both soluble and transmembrane markers 
(sulfated secretogranins, sulfated GAG chains, and VSV G 
protein blocked at TGN at 20~  to demonstrate that export 
from the distal Golgi compartments to the cell surface is po- 
tently and reversibly blocked by BFA. Since export from the 
ER is similarly inhibited, we suggest that ER to Golgi and 
Golgi to cell surface transport may share some component 
that is either identical or homologous; BFA affects such a 
component(s) and thus blocks export from both compart- 
ments. The situation would be similar to the N-ethylmale- 
imide-sensitive factor (Block et al., 1988) or the yeast Secl8 
gene product (Eakle et al., 1988; Wilson et al., 1989), which 
functions at multiple steps  (Block et al.,  1988;  Beckers, 
1989; Graham and Emr, 1991; Diaz et al., 1989). In contrast 
to these generalized factors, involvement of small molecular 
weight GTP-binding proteins in transport is step specific (for 
review see Balch, 1990).  Likewise, Sec23p appears to par- 
ticipate in vesicle budding only in early secretory compart- 
ments of yeast cells (Kaiser and Schekman, 1990;  Graham 
and Emr, 1991) and is localized specifically to the ER transi- 
tional elements, but not the Golgi elements, in mammalian 
cells (Orci et al.,  1991). 
Using  "I'GN-38 and  mannose-6-phosphate  receptor  as 
markers for the TGN, Lippincott-Schwartz et al. (1991) and 
Wood et al. (1991) showed that BFA induces mixing of TGN 
with early endosomes, resulting in an increase in cell surface 
mannose-6-phosphate receptor and uptake of anti-TGN-38 
antibodies. Thus, at least for these two proteins, traffic be- 
tween TGN and the cell surface appears to continue in BFA. 
In this regard, it is surprising that transport of VSV G and 
sulfated GAG chains and secretogranins to the cell surface 
is  inhibited.  There  are  two  possible  explanations.  First, 
"I'GN-38 and mannose-6-phosphate receptor may reside in a 
different compartment from VSV G at 20~  or sulfated GAG 
chains and secretogranins. For VSV G protein, however, this 
is not very likely since it has been colocalized to the same 
compartment as TGN-38 in NRK cells by immunoelectron 
microscopy (Luzio et al., 1990).  Another possibility is that 
TGN-38  and  mannose-6-phosphate  receptor  may have  a 
different itinerary from VSV G protein and secreted proteins 
(for instance, at least mannose-6-phosphate receptor nor- 
mally recycles between endosomes and TGN), and are thus 
affected differently by BFA. Future work is necessary to dis- 
tinguish between these possibilities. 
Several  proteins of the  transport  machinery have been 
shown to be affected by BFA (Donaldson et al., 1990).  One 
of these, B-COP (Waters et al., 1991; Allan and Kreis, 1986; 
Malhotra, 1989; Serafini et al., 1991), is a component of the 
coatomer found on nonclathrin-coated vesicles. One possi- 
bility is that this coat complex participates in multiple steps, 
generating forward-bound transport vesicles from ER transi- 
tional elements, Golgi cisternae, and the TGN. BFA causes 
redistribution of this coat complex from the membrane to the 
cytosol, thereby preventing forward movement of proteins 
from the ER to the Golgi cisternae and also from the TGN 
to the cell surface. In support of this view, ~COP is found 
to colocalize with VSV G protein when export from the ER 
and TGN is blocked at 15~  and 20~  respectively (Duden 
et al., 1991b; Miller, S. G., and H.-P. Moore, unpublished 
observations). This distribution is consistent with a role in 
both export from the ER and the TGN. The time course of 
inhibition is also consistent with this hypothesis; inhibition 
of export from the TGN is rapid (well within 15 min, data 
not shown), as is the dissociation of B-COE An alternative 
interpretation proposed earlier is that the coatamer complex 
may function as a dynamic framework, or scaffold, to main- 
tain the structure of the Golgi complex and the selectivity of 
membrane budding and/or fusion (Duden et al., 1991a). At 
the present time, it is not easy to determine which of these 
two roles the coatomer plays. However, if it functions to pro- 
vide membrane selectivity, it is not easy to explain why dis- 
sociation of B-COP from the TGN does not cause it to co- 
alesce with other Golgi cisternae and the ER (see below). 
A surprising finding is that BFA prevents secretion via the 
constitutive and the regulated secretory pathways. This is not 
expected if B-COP is the target of BFA, since clathrin has 
been found to be associated with incipient regulated secre- 
tory granules (Orci et al., 1985) and has been generally as- 
sumed to be the coat for budding regulated secretory gran- 
ules. One possibility is that B-COP is not the direct target 
for BFA. Rather, the target(s) for BFA may be components 
essential for assembly of a variety of different coats. Indeed, 
it was recently reported that BFA causes selective dissocia- 
tion of clathrin and adaptors from the Golgi but not from the 
plasma membrane in VERO cells and MDCK cells (Robin- 
son and Kreis, 1992; Wong, D. H., and E  M. Brodsky, un- 
published results).  Similar results  were obtained in BHK 
cells (Miller, S., and H.  P.  Moore, unpublished observa- 
tions).  Furthermore,  Ktistakis et al.  (1991) used  a  BFA- 
resistant cell line, PtK1, in cell fusion studies to show that 
the target for BFA is a nondiffusable factor. B-COP, on the 
other hand, appears to be in dynamic equilibrium with the 
Golgi membranes: a large fraction of the coatomer complex 
is found in the soluble fraction, where it comprises ~0.2 % 
of total cytosolic protein (Waters et al., 1991); it dissociates 
from the membrane when cells are depleted of  ATP (Donald- 
son et al.,  1991); and GTP3,S,  which blocks intracetlular 
transport, prevents its dissociation by BFA (Donaldson et al., 
1991).  Thus, it is more likely that the targets of BFA are 
membrane-associated proteins involved in the assembly of 
coats,  such as the yeast SEC12  gene product, an integral 
membrane glycoprotein (Nakano et al., 1988) that interacts 
with the low molecular weight GTP-binding protein, Sarlp 
(Nakano and Muramatsu, 1989) in the formation of ER vesi- 
cles (d'Enfert et al., 1991). Further work will be necessary 
to determine if the inhibitory effects of BFA on export via 
the constitutive and the regulated pathway is due to dissocia- 
tion of nonclathrin, and clathrin coats form the TGN, respec- 
tively. It should be noted that our conclusion of blockage to 
regulated secretory pathway is based on the assumption that 
tyrosine sulfation occurs at least in part in the TGN. This is 
likely to be the case since it has been shown that tyrosine sul- 
fation is the last modification  before exit from the TGN, after 
sialylation (Baeuerle and Huttner,  1987),  and that tryosyl- 
protein sulfotransferase is itself sialylated (Niehrs and Hutt- 
ner, 1990).  Since a significant fraction of the sialyltransfer- 
ase resides in the TGN (Roth  et al.,  1985;  Berger et al., 
1987),  it is  reasonable  to  assume that this compartment 
represents a major site for tyrosine sulfation. 
Our data, in conjunction with earlier studies, suggest that 
the exo/endocytic compartments may be composed of two 
similar but distinct membrane systems; the ER/cis-/medial- 
/trans-Golgi  system, and the TGN/ceU  surface/endosomal 
system. Both systems are similarly affected by BFA; i.e., for- 
Miller et al. Post-Golgi Membrane Tragic and Brefeldin A  281 ward traffic stops  but  return traffic continues,  suggesting 
similar  structural organizations.  NormaUy, these  two sys- 
tems  must be in communication in the forward direction 
since proteins  in the biosynthetic  pathway traverse  Golgi 
compartments and the  TGN. BFA blocks  this  forward trans- 
port,  severing communication between the two systems. The 
fact that the two systems do not become intermingled also 
suggests that either there is little or no backward transport 
between the systems, or, it it exists, the mechanism must be 
quite  different from  that operating  between  other  Golgi 
cisternae.  This  could  provide a regulatory  mechanism  to 
control  communication  between  the  "outer" and  "inner" 
membrane systems. 
In summary, much remains to be learned about the bio- 
chemical components that mediate protein traffic through the 
constitutive and regulated exocytic pathways as well as in the 
endocytic pathway. However, the data presented in this paper 
provide some important constraints about the components 
involved in the exo/endo systems. Future experiments will be 
important to address questions such as whether the coatomer 
complex functions as a budding component or as a scaffold, 
and whether Secl2p like protein(s) function in multiple steps 
and is the primary target for BFA. 
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